SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-046340
Filing Date
2021-07-12
Accepted
2021-07-12 18:57:46
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 17522
  Complete submission text file 0001209191-21-046340.txt   18871
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O UROGEN PHARMA LTD. 9 HA'TA'ASIYA STREET RA'ANANA L3 4365007
Business Address
Barrett Elizabeth A. (Reporting) CIK: 0001764157 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38079 | Film No.: 211086387